CatchU Intervention for Sensory Disorders

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
Sensory Disorders+4 More
CatchU Intervention - Other
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

The ability to successfully integrate information across sensory systems is a vital aspect of functioning in the real world. To date, only a few studies have investigated the clinical translational value of multisensory integration processes. Previous work has linked the magnitude of visual-somatosensory integration (measured behaviorally using simple reaction time tasks) to important cognitive (attention) and motor (balance, gait, and falls) outcomes in healthy older adults. While multisensory integration effects have been measured across a wide array of populations using various sensory combinations and different neuroscience approaches, a gold standard for quantifying multisensory integration has been lacking. The investigator recently developed a step-by-step protocol for administering and calculating multisensory integration effects in an effort to facilitate innovative and novel translational research across diverse clinical populations and age-ranges. However, patients with severe medical conditions and/or mobility limitations often experience difficulty traveling to research facilities or joining time-demanding research protocols. Using the aforementioned protocol, the study team invented a mobile multisensory falls-assessment iPhone app called CatchU to facilitate physician discussion and counseling of falls in older adults during clinical visits (e.g., annual wellness visits with a subsequent telehealth call), in an attempt to alleviate disability, promote independence, and increase quality of life for older adults. The investigator team has provided a cross-sectional research proposal for a pilot study of 300 patients (over a 24-month period) in order to demonstrate acceptable-to-excellent predicative accuracy of CatchU for identifying older adults at-risk for falls.

Eligible Conditions

  • Age Problems
  • Well Aging
  • Sensory Disorders
  • Falls Injury

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Sensory Disorders

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 24 months

24 months
Falls

Trial Safety

Safety Progress

1 of 3

Other trials for Sensory Disorders

Trial Design

2 Treatment Groups

Control
1 of 2
CatchU Intervention
1 of 2
Active Control
Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: CatchU Intervention · No Placebo Group · N/A

CatchU Intervention
Other
Experimental Group · 1 Intervention: CatchU Intervention · Intervention Types: Other
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 months
Closest Location: Albert Einstein College of Medicine/Montefiore Medical Center · Bronx, NY
Photo of Bronx 1Photo of Bronx 2Photo of Bronx 3
2022First Recorded Clinical Trial
1 TrialsResearching Sensory Disorders
1 CompletedClinical Trials

Who is running the clinical trial?

Jeannette MahoneyLead Sponsor
Albert Einstein College of MedicineOTHER
263 Previous Clinical Trials
1,838,427 Total Patients Enrolled
Montefiore Medical CenterOTHER
403 Previous Clinical Trials
553,192 Total Patients Enrolled
Burke Rehabilitation HospitalOTHER
8 Previous Clinical Trials
636 Total Patients Enrolled
Jeannette R Mahoney, PhDPrincipal InvestigatorAlbert Einstein College of Medicine

Eligibility Criteria

Age 65+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are able to understand and communicate in English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.